Comparative analysis of logarithm of the minimum angle of resolution best corrected visual acuity in Central serous chorioretinopathy patients treated  with 1% brinzolamide and control group

Dr Jyoti Sharma, Dr Jitender, Dr Deepti

Comparative analysis of logarithm of the minimum angle of resolution best corrected visual acuity in Central serous chorioretinopathy patients treated with 1% brinzolamide and control group

Authors

Dr Jyoti Sharma, Dr Jitender, Dr Deepti

Keywords:

Central serous chorioretinopathy, best-corrected visual acuity, 1% brinzolamide, Carboxy methyl cellulose

Abstract

Background: The retinal condition known as central serous chorioretinopathy (CSR) impairsvision acuity. In this study, the impact of placebo (carboxymethyl cellulose) (Group B) and 1%brinzolamide (Group A) in enhancing logMAR Best-Corrected Visual Acuity (BCVA) throughouta 3-month follow-up was evaluated

References

Gupta A, Tripathy K. Central Serous Chorioretinopathy. [Updated 2023 Aug 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558973/

Karimi S, Payandeh N, Mahmoudi Nejad Azar S, Nouri H, Abtahi SH. Central Serous Chorioretinopathy Risk Factors in An Iranian Cohort: A Case-control Study. J Ophthalmic Vis Res. 2023 Nov 30;18(4):410-416. doi: 10.18502/jovr.v18i4.14553.

Downloads

Published

2025-05-03

How to Cite

Dr Jyoti Sharma, Dr Jitender, Dr Deepti. (2025). Comparative analysis of logarithm of the minimum angle of resolution best corrected visual acuity in Central serous chorioretinopathy patients treated with 1% brinzolamide and control group. International Journal of Pharmacy Research & Technology (IJPRT), 15(1), 522–530. Retrieved from https://www.ijprt.org/index.php/pub/article/view/416